Everyone Healthy Library
Stomach Cancer
Also Known As: Gastric Cancer
Condition / disease reference page from the Everyone Healthy database.
Connected health information
Explore this condition in a clear order
Condition overview
Attributes
Commonalityis rare
Commonality for Afghanistanis uncommon
Commonality for Australiais rare
Commonality for Central Africais uncommon
Commonality for Central Americais rare
Commonality for Chinais uncommon
Commonality for East Africais rare
Commonality for North Africais rare
Commonality for North Americais rare
Commonality for Pakistanis uncommon
Commonality for Russiais uncommon
Commonality for South Africais rare
Commonality for Southern Indiais rare
Commonality for Sub Saharan Africais rare
Commonality for Zimbabweis rare
Incidenceis approximately 1 in 11,759 people
Incidenceis approximately 1 in 11,628 people
Linked signs and symptoms
21Each sign/symptom opens its own page and links back to related conditions.
- Abdominal Bloating
- Abdominal Mass
- Anaemia (Anemia)
- Appetite Loss (Anorexia)
- Bloating
- Constipation
- Diarrhoea (Diarrhea)
- Early Satiety (Feeling Full Quickly)
- Fatigue
- Heartburn (Pyrosis)
- Liver Enlarged Or Tender
- Lymph Nodes Swollen (Glands)
- Nausea
- Pain Abdominal
- Pain in Upper Abdomen (Epigastric Burning)
- Skin Yellowing (Jaundice)
- Swallowing Difficulty (Dysphagia)
- Vomiting
- Vomiting Blood (Hematemesis)
- Weakness
- Weight Loss (Body Mass Index Decreased)
Linked drugs / medications
3Medication information is educational only. A doctor or pharmacist should advise whether any medicine is appropriate.
Treatments, therapies and supportive options
28Grouped by treatment type. These are educational database links, not personal treatment recommendations. Evidence labels are shown only where stored in the EH database.
Surgery
6Endoscopic procedures
2Medical therapy
10- Billroth IWeakly in Favour(Low Evidence)
- Billroth IIWeakly in Favour(Low Evidence)
- ChemotherapyWeakly in Favour(Low Evidence)
- Endoscopic Mucosal ResectionWeakly in Favour(Low Evidence)
- Endoscopic Submucosal ResectionWeakly in Favour(Low Evidence)
- GastrectomyWeakly in Favour(Low Evidence)
- Lymph Node ResectionWeakly in Favour(Low Evidence)
- Radiation TreatmentWeakly in Favour(Low Evidence)
- ResectionWeakly in Favour(Low Evidence)
- StentingWeakly in Favour(Low Evidence)
Alternative and complementary therapies
3Alternative medicine
3Vitamins and minerals
2Linked diagnostic tests and investigations
38These are pulled from both EH diagnostic-test link tables, including the older large test-link table.
- Alpha-1 Antitrypsin (AAT) Concentration
- Alpha-Fetoprotein (AFP, Serum AFP, Blood)
- Ankle-Brachial Index
- Antithrombin 111 (AT-111) Activity Test
- Barium X-Ray
- Blood Uric Acid Concentration Test
- Cerebrospinal Fluid Glucose Concentration
- Cerebrospinal Fluid Protein Concentration
- Cerebrospinal Fluid White Cell Differential
- Chest X-Ray
- Computerized Tomography (CT) Scan
- D-Dimer Blood Test
- D-Dimer Blood Test
- Doppler Ultrasound
- Endoscopic Ultrasound (EUS)
- Eosinophils Count
- Esophagogastroduodenoscopy (aka EGD or OGD)
- Fecal Occult Blood Test
- Fibrin Degradation Products (FDPs, Fibrin Split Products, FSPs, Fibrin Breakdown Products, Fbps)
- Fibrin Monomers Test
- Fibrinogen Concentration test
- Fibrinopeptide A (FPA) Action Assay
- Folic Acid (Folate) Concentration
- Gastrin Concentration
- haptoglobin (Hp) concentration
- Iron Concentration
- Low Density Lipoprotein (LDL) Concentration
- magnetic Resonance Angiogram (MRA)
- Neutrophil Absolute Count
- Potassium Concentration (K, Blood)
- Protein Electrophoresis (Blood, Serum Protein)
- Thyroid Stimulating Horomone (TSH) Concentration
- Thyroxine (Total T4) Concentration
- Triiodothyronine (Free T3) Concentration
- Triiodothyronine (Total T3) Concentration
- Triiodothyronine Uptake Test
- Venography
- Vitamin B12 (VB12) Concentration
Biological and test markers
29This visual map uses existing EH database links to show biological agents and lab markers reported as increased, decreased, or associated with this condition. These are educational relationships only; test results must be interpreted by a qualified clinician because ranges vary by lab, method, age, sex and clinical context.
Often increased
19- Alpha-1 Antintrypsin (AAT)Reference range exampleAdult ( > 16y): 90–215 mg/dLLinked diagnostic tests1Alpha-1 Antitrypsin (AAT) Concentration
- Alpha-Fetoprotein (Non-Pregnant, Serum)Reference range exampleAll: 5–40 ng/mLLinked diagnostic tests1Alpha-Fetoprotein (AFP, Serum AFP
- Cerebrospinal Fluid LeukocytesReference range exampleAdult ( > 16y): 0–5 /µL; 1y - 6y: 0–20 /µLLinked diagnostic tests1Cerebrospinal Fluid White Cell Differential
- Cerebrospinal Fluid Neutrophil DifferentialReference range exampleAll: 0–5 %Linked diagnostic tests1Cerebrospinal Fluid White Cell Differential
- Cerebrospinal Fluid Total ProteinReference range exampleAdult ( > 16y): 15–45 mg/dL; Child (< 10y): 15–70 mg/dLLinked diagnostic tests1Cerebrospinal Fluid Protein Concentration
- D-DimerReference range exampleAdult ( > 16y): 0–240 µg/LLinked diagnostic tests1D-Dimer Blood Test
- EosinophilsReference range exampleAdult ( > 16y): 0–3 %; 0–3 %Linked diagnostic tests3Differential White Blood Cell Count Tests, Eosinophil Differential Of Total WBC
- Fecal BloodReference range exampleAll: 0–2 mLLinked diagnostic tests1Fecal Occult Blood Test
- Fibrin MonomersReference range example0–10,000 µg/LLinked diagnostic tests1Fibrin Monomers Test
- Fibrin Split ProductsReference range exampleAll: 0–1 mg/dLLinked diagnostic tests1Fibrin Degradation Products (FDPs, Fibrin Split Products
- FibrinogenReference range exampleAdult ( > 16y): 150–400 mg/dLLinked diagnostic tests1Fibrinogen Concentration test
- Fibrinopeptide A (FPA)Reference range exampleAdult ( > 16y), Female: 0.7–3.1 mg/mL; Adult ( > 16y), Male: 0.35–2.5 mg/mLLinked diagnostic tests1Fibrinopeptide A (FPA) Action Assay
- Gamma Globulin (Blood, Serum)Reference range exampleAll: 0.8–1.7 gm/dLLinked diagnostic tests1Protein Electrophoresis (Blood, Serum Protein)
- GastrinReference range exampleAdult ( > 16y): 0–120 pg/mLLinked diagnostic tests1Gastrin Concentration
- haptoglobin (Hp)Reference range example45–200 mg/dLLinked diagnostic tests1haptoglobin (Hp) concentration
- Segmented NeutrophilsReference range exampleAdult ( > 16y): 50–62 %; Adult ( > 16y): 2,500–8,000 mm3Linked diagnostic tests2Differential White Blood Cell Count Tests, Neutrophil Absolute Count
- Thyroid Stimulating Horomone (TSH)Reference range exampleAdult ( > 16y): 0.021–0.11 µg/dL; Newborn (0 - 1month): 0.04–0.19 µg/dLLinked diagnostic tests2Thyroid Stimulating Horomone (TSH) Concentration, Urine B2 Microglobulin Concentration
- Triiodothyronine Uptake PercentageReference range exampleAll: 25–38 %Linked diagnostic tests1Triiodothyronine Uptake Test
- Uric Acid, BloodReference range exampleAdult ( > 16y), Female: 2.5–7 mg/dL; Adult ( > 16y), Male: 4–8 mg/dLLinked diagnostic tests1Blood Uric Acid Concentration Test
Often decreased
10- Antithrombin 111 (AT-111)Reference range exampleAdult ( > 16y): 90–110 %Linked diagnostic tests1Antithrombin 111 (AT-111) Activity Test
- Folic Acid (Folate)Reference range exampleInfant (0 - 1y): 14–51 ng/mL; Child (0 - 16y): 5–21 ng/mLLinked diagnostic tests1Folic Acid (Folate) Concentration
- Glucose (Cerebrospinal Fluid)Reference range exampleChild (0 - 16y): 65–85 mg/dL; Adult ( > 16y): 50–72 mg/dLLinked diagnostic tests1Cerebrospinal Fluid Glucose Concentration
- IronReference range exampleChild (0 - 16y): 50–120 µg/dL; Adult ( > 16y), Female: 50–150 µg/dLLinked diagnostic tests2Iron Concentration, Total Iron Binding Capacity (TIBC)
- Low Density Lipoprotein (LDL)Reference range exampleAdult ( > 16y): 0–125 mg/dL; 6y - 16y: 0–100 mg/dLLinked diagnostic tests1Low Density Lipoprotein (LDL) Concentration
- Potassium (K, Blood)AbbreviationKReference range exampleInfant (0 - 1y): 4.1–5.3 mEq/L; Child (0 - 16y): 3.4–4.7 mEq/LLinked diagnostic tests1Potassium Concentration (K, Blood)
- Thyroxine (Total T4)Reference range exampleAdult ( > 16y), Female: 6–12 µg/dL; Adult ( > 16y), Male: 5–12 µg/dLLinked diagnostic tests1Thyroxine (Total T4) Concentration
- Triiodothyronine (Free T3)Reference range example2.7–4.9 pg/mLLinked diagnostic tests1Triiodothyronine (Free T3) Concentration
- Triiodothyronine (Total T3)Reference range exampleInfant (0 - 1y): 1.1–2.43 ng/mL; Adult ( > 16y): 1–2.1 ng/mLLinked diagnostic tests1Triiodothyronine (Total T3) Concentration
- Vitamin B12 (VB12)Reference range exampleAdult ( > 16y): 130–670 pmol/LLinked diagnostic tests1Vitamin B12 (VB12) Concentration
Other associated markers
0No markers in this group.
Introduction / full article
Stomach Cancer
Efficacy of Alternative and Other Treatments According to GRADE* Ranking:
Turmeric [4, 16, 17, 18, 19, 20, 21]:
Please note, this management does NOT treat the condition itself. It is proposed only as a weak supportive symptomatic support, and even then, has insufficient evidence to back up this claim at present.
Recommendation: Weakly in favor (Early laboratory studies show that turmeric may be of benefit in the treatment of cancer. However, clinical trials on humans are needed)
Grade of Evidence: low quality of evidence
Rabdosia Rubescens (Dong Ling Cao, Oridonin, Isodon Rubescens) [4, 10, 11, 12, 13, 14, 15]:
Please note, this management does NOT treat the condition itself. It may mildly help with some of the symptoms, and even then has insufficient evidence to back up this claim at present.
Recommendation: weakly in favor (Laboratory studies show that rabdosia rubescens has anti-cancer activity, and may be helpful in the treatment of stomach cancer. However, more studies are needed)
Grade of Evidence: low quality of evidence
Green Tea [4, 5, 6, 7, 8, 9]:
Please note, this management does NOT treat the condition itself. It may mildly help with some of the symptoms, and even then has insufficient evidence to back up this claim at present.
Recommendation: Weakly in favor (Laboratory studies have shown promise with regards to the prevention of stomach cancer with green tea, but very few reliable clinical trials have been done. More research is needed.)
Grade of Evidence: low quality of evidence
* www.gradeworkinggroup.org
Summary References
Treatments:
1. http://www.merck.com/mmpe/sec02/ch021/ch021d.html?qt=cancer&alt=sh#sec02-ch021-ch021b-1448
2. http://gut.bmj.com/content/48/2/225.abstract
3. http://www.ncbi.nlm.nih.gov/pubmed/8658220
4. Ades T, Alteri R, Gansler T, Yeargin P, "Complete Guide to Complimentary & Alternative Cancer Therapies", American Cancer Society, Atlanta USA, 2009
5. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/green-tea
6. http://www.ncbi.nlm.nih.gov/pubmed/16968850
7. http://www.denverpost.com/nationworld/ci_4326770
8. http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-green_tea.html
9. http://nccam.nih.gov/health/greentea/index.htm
10. http://naturaldatabase.therapeuticresearch.com/nd/Search.aspx?fs=ND&pt=100&id=1140&AspxAutoDetectCookieSupport=1
11. http://mct.aacrjournals.org/content/4/4/578.abstract
12. http://www.ncbi.nlm.nih.gov/pubmed/15586232
13. http://www.webmd.com/vitamins-supplements/ingredientmono-1140-RABDOSIA RUBESCENS.aspx?activeIngredientId=1140&activeIngredientName=RABDOSIA RUBESCENS
14. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/rabdosia-rubescens
15. http://alternativehealing.org/dong_ling_cao.htm
16. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/turmeric
17. http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-turmeric.html
18. http://nccam.nih.gov/health/turmeric/index.htm
19. http://news.bbc.co.uk/2/hi/health/1668932.stm
20. http://www.mirror.co.uk/news/top-stories/2009/10/28/curry-kills-cancer-cells-and-other-health-benefits-of-the-nations-favourite-dish-115875-21779950/
21. http://clinicaltrials.gov/ct2/results?term=turmeric